BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180418
DTEND;VALUE=DATE:20180520
DTSTAMP:20260729T200842
CREATED:20180418T091246Z
LAST-MODIFIED:20180418T091427Z
UID:19875-1524009600-1526774399@ces.b2sg.org
SUMMARY:Program Co-Leader - CMG
DESCRIPTION:The Virginia Commonwealth University (VCU) School of Medicine and Massey Cancer Center are seeking a successful scientist and leader to serve as the Program Co-Leader of the Cancer Molecular Genetics (CMG) research program at the cancer center. The CMG program consists of a multidisciplinary group of 26 investigators from 12 academic departments representing four schools. This tenure-eligible faculty position will be a key member of Massey’s leadership team. Responsibilities: \n-Provide oversight\, development\, implementation and evaluation of cancer molecular genetics related programs and initiatives at Massey Cancer Center \n-Partner with the Director\, Associate Directors and other Program Leaders at Massey to enhance the cancer center’s scientific goals and objectives \n-Work closely with leadership to encourage and facilitate multidisciplinary collaboration and translational research at the cancer center \n-Conduct fundamental research that can be translated into improved approaches for diagnosis\, prevention\, and treatment of neoplastic diseases Research can include but not limited to the following areas: -Epigenetic mechanisms in cancer development and progression: Understanding the regulation and interaction of histone modifications and other epigenetic controls including DNA methylation and miRNA; recognition of these post-translational modifications in DNA-chromatin complexes by nucleosome remodeling factors\, and the role of miRNA in these processes \n-Definition of the functional significance of genes involved in cancer development and progression\, and exploiting this information to identify and validate promising targets \n-Definition of the pathways that delete and silence tumor suppressor genes in human cancers \n\n\n\n\nMinimum Qualifications \n-PhD or MD/PhD \n-Area of cancer research expertise in epigenetics or epigenomics \n-Solid track record of scientific achievement reflected by both sustained and recent impactful publications and extramural peer-reviewed research funding in cancer related research as a Principal Investigator \n\n\n\n\nPreferred Qualifications \n-Proven leadership\, relationship building\, and strong communication skills \n-Experience working in a matrix environment within academic medicine \n-Proven success in collaborating with multi-disciplinary teams \n-Demonstrated experience working with and fostering diverse faculty\, staff\, and student environment or commitment to do so as a faculty member at VCU \n\n\n\n\nSpecial Requirements \nThe Program Co-Leader\, Cancer Molecular Genetics is responsible for the oversight\, development\, implementation and evaluation of the cancer molecular genetics related programs and initiatives at Massey Cancer Center.
URL:https://ces.b2sg.org/event/vcu-18apr18/
LOCATION:Virginia Commonwealth University\, 907 Floyd Ave\, Richmond\, VA\, 23284\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/09/VCU-virginia-commonwealth-e1506279590219.jpg
END:VEVENT
END:VCALENDAR